Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Graphite Bio Inc
(NQ:
GRPH
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Mar 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Graphite Bio Inc
< Previous
1
2
Next >
Graphite Bio Announces Participation in H.C. Wainwright Gene Therapy and Gene Editing Virtual Conference
March 28, 2022
From
Graphite Bio, Inc.
Via
Business Wire
Graphite Bio Announces Formation of Scientific Advisory Board
March 23, 2022
From
Graphite Bio
Via
Business Wire
Graphite Bio Reports Recent Business Progress and Fourth Quarter and Fiscal Year 2021 Financial Results
March 21, 2022
From
Graphite Bio, Inc.
Via
Business Wire
Graphite Bio Announces Participation in Upcoming Investor Conferences
January 27, 2022
From
Graphite Bio, Inc.
Via
Business Wire
Graphite Bio Presents Overview of Phase 1/2 CEDAR Trial Evaluating Investigational Gene Editing Therapy GPH101 in Sickle Cell Disease at 63rd ASH Annual Meeting and Exposition
December 11, 2021
From
Graphite Bio, Inc.
Via
Business Wire
Graphite Bio to Host Key Opinion Leader Webinar on Gene Correction for Sickle Cell Disease
December 07, 2021
From
Graphite Bio, Inc.
Via
Business Wire
Graphite Bio Enrolls First Patient in Phase 1/2 Clinical Trial of GPH101 for Sickle Cell Disease
November 17, 2021
From
Graphite Bio, Inc.
Via
Business Wire
Graphite Bio Reports Recent Business Progress and Third Quarter 2021 Financial Results
November 10, 2021
From
Graphite Bio, Inc.
Via
Business Wire
Graphite Bio Announces Presentation on Phase 1/2 CEDAR Trial of GPH101 in Sickle Cell Disease at Upcoming 63rd ASH Annual Meeting and Exposition
November 04, 2021
From
Graphite Bio, Inc.
Via
Business Wire
Graphite Bio Announces Participation in Upcoming Jefferies Gene Therapy/Editing Summit
October 21, 2021
From
Graphite Bio, Inc.
Via
Business Wire
Graphite Bio Presents Preclinical Data Supporting GPH101 in Sickle Cell Disease at 49th Annual Sickle Cell Disease Association of America National Convention
October 12, 2021
From
Graphite Bio, Inc.
Via
Business Wire
Graphite Bio Announces Upcoming Presentation at 49th Annual Sickle Cell Disease Association of America National Convention
October 05, 2021
From
Graphite Bio, Inc.
Via
Business Wire
Graphite Bio Announces Participation in Upcoming September Investor Conferences
August 30, 2021
From
Graphite Bio, Inc.
Via
Business Wire
Graphite Bio Reports Recent Business Progress and Second Quarter 2021 Financial Results
August 12, 2021
From
Graphite Bio, Inc.
Via
Business Wire
Graphite Bio Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
June 30, 2021
From
Graphite Bio, Inc.
Via
Business Wire
Graphite Bio Announces Pricing of Upsized Initial Public Offering
June 24, 2021
From
Graphite Bio, Inc.
Via
Business Wire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.